Larimar Therapeutics, Inc. current report, 24 September 2015

Business Context and Reporting Period

This Form 8-K was filed by Zafgen, Inc. on September 24, 2015. The report details significant changes to the Company's Board of Directors, including the election of two new directors and the scheduled departure of two existing directors.

Key Financial Metrics

The filing does not provide financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. The only financial data disclosed relates to director compensation arrangements:

  • Consulting Fee: $5,000 per day for services provided by Robert J. Perez through Vineyard Sound Advisors, LLC.
  • Compensation Cap: Aggregate compensation exceeding $25,000 in any quarter will be paid in shares of common stock rather than cash.
  • Director Compensation: New directors will receive standard cash and equity compensation under the non-employee director program.

Material Changes

The primary material change is the restructuring of the Board of Directors effective September 24, 2015, with full transition occurring by December 8, 2015:

  • Elections: Robert J. Perez (former CEO of Cubist Pharmaceuticals) and Cameron Geoffrey McDonough (CEO of Swedish Orphan Biovitrum AB) were elected to the Board.
  • Departures: Kevin P. Starr and Avi Goldberg are resigning from the Board, effective December 8, 2015.
  • Consulting Agreement: A new agreement was entered into with Vineyard Sound Advisors, LLC, dated September 29, 2015, to provide consulting services to the Company.

Guidance, Outlook, and Risks

The filing does not contain financial guidance, outlook, or management commentary regarding business operations. The document notes that there are no arrangements or understandings between the new directors and other persons regarding their election. The Company will cover reasonable business and travel expenses for the consulting services provided by Mr. Perez.

Investor Verification Checklist

  • Verify the effective date of the Board transition (December 8, 2015) and the impact on board composition.
  • Review the specific terms of the Consulting Agreement with Vineyard Sound Advisors, LLC, particularly the equity conversion threshold.
  • Confirm the professional backgrounds of the new directors (Perez and McDonough) to assess their strategic fit for Zafgen.
  • Check subsequent filings for any financial impact resulting from the new consulting arrangement or director compensation.